Metabolism, Pharmacokinetics, and Bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)

Oncotarget - United States
doi 10.18632/oncotarget.21808
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Selective Estrogen Receptor Modulators

2006English

Pharmacokinetics of the Estrogen Receptor Subtype-Selective Ligands, PPT and DPN: Quantification Using UPLC-ES/MS/MS

Journal of Pharmaceutical and Biomedical Analysis
Clinical BiochemistryDrug DiscoveryAnalytical ChemistrySpectroscopyPharmaceutical Science
2012English

Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors

Journal of Neuroscience
Neuroscience
2019English

Structure of Estradiol Metal Chelate and Estrogen Receptor Complex: The Basis for Designing a New Class of Selective Estrogen Receptor Modulators

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2011English

Pharmacokinetics and Bioavailability of Difloxacin in Camel

Journal of Veterinary Medical Research
2005English

Selective Binding of the Estrogen Receptor to One Strand of the Estrogen Responsive Element

Nucleic Acids Research
Genetics
1993English

Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

2013English

Pharmacokinetics, Metabolism, and Excretion of [14C]Esaxerenone, a Novel Mineralocorticoid Receptor Blocker in Humans

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Impact of Isotype Selective Estrogen Receptor Agonists on Ovarian Function

Experimental and Clinical Endocrinology and Diabetes
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy